Prostarm Info Systems has informed that pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended and the Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading, the Trading Window for dealing in Securities of the Company for all Designated Persons and their Immediate Relatives of the Company shall remain closed with effect from Thursday, January 01, 2026, until 48 hours after the declaration of Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended December 31, 2025. Accordingly, all the Designated Persons, their Immediate Relatives and other Insiders of the Company are advised not to deal in the Equity Shares of the Company during the aforesaid period. Further, the date of the Board Meeting in which the financial results are to be approved will be informed to the Stock Exchanges in due course. The said intimation shall also be available on website of the Company at www.prostarm.com.
The above information is a part of company’s filings submitted to BSE.
